Needham Reiterates Buy on DocGo, Maintains $3 Price Target
DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript
Transcript: DocGo Q2 2026 Earnings Conference Call
DocGo Signs Agreement To Acquire Hicuity Health; Hicuity Health Shareholders To Get 2% Of DocGo's Common Shares
DocGo Narrows FY2026 Sales Guidance from $300.000M-$315.000M to $305.000M-$310.000M vs $306.281M Est
DocGo Q2 EPS $(0.16) Misses $(0.06) Estimate, Sales $73.425M Miss $75.404M Estimate
DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
DocGo Granted Additional 180-Day Nasdaq Extension Through Jan. 25, 2027 To Regain Compliance
DocGo Extends Share Repurchase Program Expiration To December 31
DocGo Inc. (DCGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
DocGo Unit PTI Health Launches Mobile Phlebotomy Services In Southern Florida
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport
US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results
DocGo Inc (DCGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges
DocGo Inc. (DCGO) Q1 2026 Earnings Call Transcript
DocGo Q1 Earnings Call Highlights
DocGo (DCGO) Q1 2026 Earnings Transcript
DocGo Inc. (DCGO) Reports Q1 Loss, Beats Revenue Estimates
DocGo (NASDAQ:DCGO) Rallies on Strong Core Growth as Migrant Revenue Winds Down
DocGo Announces First Quarter 2026 Results
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.